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AIMS AND OBJECTIVES 
The aims and objectives of the study are: 
• To retrospectively analyze patients with ankylosing spondylitis who 
underwent hip arthroplasty in our department between January 2005 
and June 2009. 
• To analyze the functional outcome in these patients after surgery 
• To analyze the improvement in the range of motion of the hip and the 
improvement in pain post operatively. 
• To compare results between patients who underwent cemented, 
uncemented and articular surface replacement. 
• To compare results between patients undergoing bilateral hip surgery 
in one stage and in two stages. 
• To radiographically analyze presence of heterotopic ossification post 
operatively. 
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LIST OF ABBREVIATIONS 
 
AS                 Ankylosing spondylitis 
THA              Total hip arthroplasty 
HLA               Human leukocyte antigen 
TNF              Tumor necrosis factor 
MRI              Magnetic resonance imaging 
NSAID          Non steroidal anti-inflammatory drug 
DMARDs      Disease modifying anti rheumatic drugs 
HO                Heterotopic ossification 
ASR              Articular surface replacement 
CRP              C Reactive protein 
ESR              Erythrocyte sedimentation rate 
MTX             Methotrexate 
US                 United States 
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INTRODUCTION 
Ankylosing spondylitis (AS), also known as Von Becheterew`s disease or 
Marie – Strumpell disease, is a chronic systemic rheumatic disorder of 
indeterminate etiology.  
It affects about 1% of the population. The age group in which AS is common is 
between 15 and 25 years. It is rare after 45 years and about 15% to 45 % of 
patients show disease onset before 16 years of age1. The younger the age of 
onset of the disease the more severe the disease is likely to be and there is a 
higher probability of the patient undergoing a total hip arthroplasty (THA)2. 
The average age of onset of AS is lower in developing nations.  
There is a higher male to female ratio of about 2:1 to 3:13. Even though the 
etiology is unknown there is an autosomal inheritance factor with a 70% 
penetrance in males and a 10% penetrance in females. This makes the relatives 
of an affected person 20-30 times more likely to develop AS compared to the 
general population4. There is a strong genetic trait such as a strong association 
with HLA-B27.  
It is the prototype and the most common disorder of a group of diseases called 
the spondyloarthropathies. The spondyloarthropathies also include reactive 
arthritis, psoriatic spondyloarthritis, spondyloarthritis of inflammatory bowel 
disease, and undifferentiated spondyloarthritis5.  
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Patients with AS may also present with peripheral arthritis, enthesitis, and acute 
anterior uveitis6. AS may be as common as rheumatoid arthritis but unlike 
rheumatoid arthritis, AS typically starts during the late teens and early 
twenties7. 
An early diagnosis is important in AS as it is associated with considerable 
disability, reduced quality of life, and high costs in terms of direct medical 
expenses and indirect costs due to lost of wages and productivity.  
It has been shown that symptoms precede radiographic changes by many years 
further delaying the diagnostic process8,9. A recent review of available evidence 
suggests that AS has to be diagnosed early and is possible prior to the 
appearance of radiological changes. With the use of MRI, confirmation of 
sacroiliitis is made much earlier to the appearance of sacroiliitis in plain 
radiography10.   
It is now clear that inflammation in AS is strongly dependent upon tumour 
necrosis factor-α (TNF-α). Dense mononuclear infiltrates containing T cells and 
macrophages, secreting TNF-α, have been observed in joints of patients with 
AS. Additionally, trials of TNF-α inhibitors in AS have yielded impressive 
results supporting the pathogenic role of TNF-α in AS11. 
Clinical features: The onset of the disease is usually insidious with the onset of 
chronic low back ache associated with stiffness that is worse late at night and in 
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the morning hours or after a long duration of rest. The stiffness is alleviated 
with physical activity. The pain is usually a dull aching pain that cannot be well 
localized and is present in the gluteal area initially on one side and which later 
progresses to both sides. The pain then progresses on to the lumbar spine. 
Authors define chronic inflammatory back pain as having at least four of the 
following features:  
• Back pain starting insidiously before the age of 45 years, of at least 3 
months duration. 
• Worsening with inactivity. 
• Improves with activity. 
• Associated with spinal morning stiffness12.  
The disease onset may be preceded by the onset of persistent or recurrent bouts 
of enthesitis and or lower limb oligoarthritis which may occur as long back as 5 
years.  
The main sites of involvement in the skeleton are in the axial skeleton 
(sacroiliac joints, hip joints, and shoulder joints) and there is occasional 
involvement of the peripheral joints13. Involvement of the costovertebral joints 
can cause severe chest pain and discomfort which worsens on coughing. The 
stiffness progresses to develop into fibrous and later bony ankylosis of the 
joints. Spinal fusion progresses to gradual development of a thoracic kyphosis14. 
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Limb joint involvement is most common in the hip and shoulders and less often 
in the knee joints or the temporomandibular joints. 
There is involvement of the sites of bony insertion of tendons which is known 
as enthesitis and predominantly occurs at sites where maximal stress occurs. 
Extraskeletal involvement in AS affects the eyes, the gastrointestinal tract, the 
heart, aorta and the lungs15. Ocular involvement can present as acute uveitis in 
20-40% of patients. Uveitis is more common in HLA B27 positive patients and 
can result in visual impairment16. 
Bowel involvement can present as asymptomatic mucosal inflammatory lesion 
in about 26-69% of patients with AS. Of these patients 6% will develop 
inflammatory bowel disease2. 
Aortic insufficiency and cardiac conduction disturbances or heart blocks are 
other uncommon extraskeletal features of AS. Aortitis of the aortic root leads to 
fibrosis. Some patients develop aortic insufficiency after aortic root dilation and 
may become haemodynamically unstable. Varying degrees of heart block are 
seen when there is inflammatory involvement of the atrioventricular conducting 
system17.  
1-2% of patients present with slowly progressing bilateral apical pulmonary 
fibrobullous or cavitatory disease18. Patients with AS are more predisposed to 
developing coronary artery disease due to the systemic inflammation19. 
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Clinical signs: The patient on examination usually has tenderness of the 
sacroiliac joint on palpation or on stressing it. Stress tests include FABERE test 
(flexion, abduction, external rotation and extension), Patrick`s tests or 
Gaenslen`s maneuvers. Lateral pelvic compression or anteroposterior pelvic 
compression tests also reveal stress tenderness. 
Mild to moderate limitation of chest expansion can be an early physical finding 
in patients with AS, and severe limitation is typically a late physical finding. 
Degree of chest expansion has limited sensitivity for diagnosis. Schober`s test 
and lateral flexion measures of spinal mobility may be better clinical indicators 
of AS20.There is a gradual flattening of the anterior chest wall, shoulders 
become stooped, the abdomen becomes protuberant, and breathing becomes 
increasingly diaphragmatic. Involvement of the cervical spine gradually results 
in progressive limitation of the ability to turn or fully extend or laterally bend 
the neck leading to an increase in the occiput-to-wall or tragus-to-wall 
distances. 
Spinal deformities take almost 10 years to evolve and do so in varying rates and 
patterns. Patients with AS can have a rigid osteoporotic spine that is prone to 
fracture after relatively minor trauma. Spinal osteoporosis is caused in part by 
the ankylosis and lack of mobility, but can also occur due to proinflammatory 
cytokines. There is a prevalence of about 19-62% of osteoporosis in terms of 
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low bone mineral density21. There is an increased risk of vertebral fractures in 
patients with AS and the relative risk is about 7.6%22.  The prevalence of 
clinical vertebral fractures is about 10-17%23. Wedging fractures of the spine 
produce a progressive kyphosis. The prevalence of major neurodeficits 
following fractures of the spine is between 29 to 91%24. 
Transverse displaced fractures of the neck are associated with significant 
morbidity and mortality and can result in paraplegia or quadriplegia. Aseptic 
spondylodiscitis is more common in patients with cervical spine disease and 
occurs mostly in the midthoracic spine. It is usually asymptomatic, and can 
occur with minimal or no trauma. Due to chronic adhesive arachnoiditis, cauda 
equina syndrome can occur, though it is a rare and late complication25. There 
have been reports of spontaneous atlanto axial subluxation26. 
Diagnosis: There is an average delay in diagnosis of 3 to 11 years from onset of 
the disease, the delay being more in women, children, adolescents and HLA 
B27 negative patients27. The longer the delay in diagnosis, the worse the 
functional outcome. This is more so in juvenile – onset AS. There have not 
been any validated criteria for diagnosis of AS. Various criteria have been 
framed. 
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1) Rome criteria (1961) were the first to be developed28. 
2) New York criteria (1966) was developed which was more specific and 
sensitive. 
3) The Modified New York criteria (1984) was developed which 
incorporated the inflammatory back pain concept29. 
The Rome criteria formulated in 1961 is still in use by clinician’s: 
Clinical criteria 
1) Low back pain and stiffness for > 3 months which is not relieved by rest. 
2) Pain and stiffness in the thoracic region. 
3) Limited motion in the lumbar spine. 
4) Limited chest expansion. 
5) History or evidence of iritis or its sequelae. 
Radiography  
1) Look for evidence of sacroiliitis. 
2) Exclude bilateral osteoarthritis. 
Ankylosing spondylitis is said to be present if: 
1) Bilateral sacroiliitis is present, AND one or more clinical criteria are 
present. 
2) Four or more clinical criteria are present. 
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• The presence of bilateral sacroiliitis is considered the most important 
criterion for the diagnosis of ankylosing spondylitis. 
The Modified New York is currently the most commonly use diagnostic criteria 
used in AS. 
Clinical criteria 
1. Low back pain and stiffness for >3 months that improves with exercise 
but not with rest. 
2. Limitation of lumbar spine mobility in both the sagittal and frontal planes 
3. Limitation in chest expansion as compared with normal range for age and 
sex 
Radiological criteria 
1. Unilateral sacroiliitis of grade 3-4* OR 
2. Bilateral sacroiliitis of grade  2 
Grading 
1. Definite AS if the radiological criterion is associated with at least 1 
clinical criterion 
2. Probable AS if : 
a. 3 clinical criteria are present OR 
b. The radiological criterion is present without any signs or symptons 
satisfying the clinical criteria. 
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Table 1: *Grading of sacroiliitis30: 
GRADE  LEVEL DESCRIPTION 
0 Normal Clear margins, uniform width, and no 
juxta-articular sclerosis. 
1 Suspicious  Suspicious but not definite abnormality. 
2 Minimal sacroiliitis Evidence of some sclerosis and minimal 
erosions but no marked joint space 
narrowing. 
3 Moderate 
sacroiliitis 
Definite sclerosis on both sides of the 
joint, erosions, and widening of the 
interosseous space. 
4 Ankylosis  Complete joint obliteration with or 
without residual sclerosis. 
 
Imaging: Radiologic evidence of sacroiliitis is the traditional hallmark in 
diagnosing AS. An anteroposterior radiograph of the pelvis in most patients is 
adequate31. However, in some patients where there is a high suspicion of AS 
when presenting early but where the sacroiliac joints are normal or shows only 
equivocal changes, a computerized tomography scan or MRI can be helpful.  
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Early changes seen on conventional radiography include squaring of the 
vertebral bodies and formation of syndesmophytes. Spondylodiscitis, 
ligamentous ossification, and involvement of the facet joints can also be 
present. Spinal osteoporosis is frequently seen in patients with AS, especially in 
patients with long term severe disease. The risk of vertebral compression 
fractures and pseudoarthrosis is increased in patients with spinal osteoporosis7. 
MRI is an excellent tool to demonstrate sacroiliitis, enthesitis and bony 
erosions. STIR technique can show ample evidence of inflammation and bone 
marrow edema, indicating active ongoing inflammation32,33. MRI also can 
detect disease-related changes in the dura mater, soft tissues, and spinal 
ligaments, as well as inflammatory changes caused by enthesitis, fractures, or 
pseudoarthrosis. MRI techniques to identify sacroiliitis are preferable in women 
of child-bearing age, in children and adolescents.  
Dual energy x-ray absorptiometry (DEXA) is useful as a screening tool for 
osteoporosis in patients with AS, but the presence of hip arthroplasty or 
extensive ligamentous ossification (bamboo spine) can influence the results. 
Enthesitis may be detected radiographically, but not in the early stages. 
Ultrasound can also detect early inflammatory changes even before they appear 
on conventional radiographs34. 
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Laboratory investigations: Ankylosing spondylitis has no specific laboratory 
markers that aid diagnosis. Acute phase reactants such as elevated C reactive 
protein (CRP) and erythrocyte sedimentation rate (ESR) are often used as part 
of the laboratory investigations of inflammatory rheumatic diseases. Elevated 
ESR and CRP are more commonly found in AS patients with peripheral 
arthritis than in those with only axial disease35. Other acute phase responses 
include elevated ferritin, mild thrombocytosis, and low albumin6. Positive 
rheumatoid factor and antinuclear antibody tests are not specific, nor are 
synovial fluid analysis and synovial biopsy .Testing for stool occult blood may 
be of value for inflammatory bowel disease. HLA-B27 testing should not be 
done routinely as AS and other spondyloarthropathies can occur in the absence 
of HLA-B27. HLA-B27 is present in healthy people (about 6% to 10% in 
Europe and slightly higher in Scandinavian countries, range 10% to16%) 36 . 
There is a risk of 20% in development of any type of spondyloarthropathy 
among HLA-B27-positive individuals with a first-degree relative with HLA 
B27- positive AS37. 
Treatment: To date treatment options in AS have been restricted to patient 
education, physical therapy, and non steroidal anti-inflammatory drugs 
(NSAID) being the mainstay of effective therapy.  
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The discovery of tumor necrosis factor-α (TNF-α) antagonists was a 
breakthrough in the treatment of AS. However despite these treatment options, 
treatment of AS has been suboptimal. Treatment involves both pharmacologic 
and non pharmacological means. Physical therapy involves exercises and 
encouragement of appropriate posture. Exercise/physical therapy programs 
have been shown to improve measures of pain, spinal mobility, patient function, 
and well-being. Supervised programs are more effective than individual at-
home programs38. 
Pharmacologic treatment: 
NSAID`s: NSAID`s are the foundation of treatment in AS. They are the first-
line drugs in the initial management of pain and stiffness. Short tern studies of 3 
months of treatment with conventional NSAID produced significant 
improvement in symptoms in patients with AS. There was significant 
improvement in spinal pain, duration of morning stiffness, night pain, 
immobility, stiffness, and peripheral pain39. The use of selective 
cyclooxegenase-2 inhibitors does not show an increased improvement in pain or 
stiffness.  
Diseases modifying ant rheumatic drugs (DMARDs): They are a potential 
second-line therapy, but their efficacy in AS is unproven. Sulfasalazine has 
been shown to improve peripheral arthritis but not back pain. Methotrexate 
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(MTX) also has not demonstrated consistent efficacy in AS-associated back 
pain, but small studies show that it has a better improvement than placebos in 
improving scores. Leflunomide, though not very effective in improving axial 
pain shows improvement in peripheral arthritis.  
Etanercept, infliximab and adalimumab are TNF- α antagonists approved by 
the US Food and Drug administration for the treatment of AS. These drugs have 
demonstrated rapid and sustained efficacy in the treatment of AS. Adverse 
reactions to TNF-α antagonists include injection site reactions, upper 
respiratory tract infections, and accidental injury. Rare cases of tuberculosis 
have been reported in patients receiving TNF-α antagonists. Infliximab and 
adalimumab carry a black-box warning highlighting the risk for tuberculosis. 
These drugs are avoided in patients with pre-existing demyelinating disease or 
moderate to severe heart failure. 
Etanercept at 25 mg twice weekly has demonstrated consistent efficacy in a 
number of clinical trials in patients with AS. Studies show an improvement in 
patient function, spine mobility, and quality of life. Some patients experienced a 
partial remission after 12 weeks of Etanercept treatment. Cessation of the drug 
caused a relapse within 3 months40. 
Infliximab used in various studies showed consistent efficacy in patients with 
partial remission seen in about 20% of infliximab treated patients. 
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Adalimumab is under investigation for the treatment of AS. In a small 20-week 
study, adalimumab 40 mg every other week produced significant improvement 
in spinal symptoms in patients with AS. Partial remission was seen in 21.6% of 
patients.  
Surgical options for treatment in AS are for the following: 
1. Treatment of painful conditions such as arthritis of the hip or knee. 
2. Providing motion in ankylosed joints. 
3. Correction of deformities as in the spine. 
4. Management of fractures. 
5. Improvement in posture. 
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REVIEW OF LITERATURE 
HIP INVOLVEMENT IN ANKYLOSING SPONDYLITIS 
Hip involvement in AS is country dependant, affecting about 30% to 50% of 
patients, with the disease being bilateral in 90 % of patients41. It affects both 
joints more commonly and occurs earlier if the disease onset is earlier42. Hip 
involvement in AS can present as arthritis of the hip, fibrous or bony ankylosis. 
Almost 40% of patients with hip involvement in AS have bony ankylosis. The 
presence of ankylosis of the hips also affects the other joints such as the knee 
and the spine also.  
The treatment of hip arthritis surgically is often postponed in young patients 
due to the age of the patients, but many studies show that arthroplasty has a 
beneficial outcome in patients. Bony ankylosis, especially when associated with 
a stiff spine, may present several exclusive challenges in its management. These 
patients are usually young and present with problems related to function, 
posture, and locomotion rather than pain. Hip involvement in AS has shown to 
increase the disease burden as well as to worsen the prognosis. Progression of 
spinal involvement is more prevalent in patients with hip involvement43. 
Hip function being a central and important function, hip impairment leads to a 
lot of disability. There is limited data on the pathophysiology and epidemiology 
of hip involvement in AS. In the early stages of the disease physical therapy and 
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pharmacological interventions can delay the progression of hip arthritis while 
the definitive treatment of end stage hip disease is hip arthroplasty. 
Definite indications for hip arthroplasty are: 
1. Ankylosis of the hips, bony or fibrous. 
2. Painful arthritis of the hip joint. 
3. For improvement in posture. 
As mentioned earlier, management of ankylosis of the hip offers unique 
problems. The patients being young the demands are more as hip function is 
very central in nature. The problems in hip ankylosis are related to function, 
deformity and locomotion rather than pain, which is the most common 
indication for surgery in the general population. The improvement in function, 
and quality of life is remarkable and significant, justifying THA in patients with 
AS. 
The problems that can arise when treating someone with AS operatively are 
technical in nature. Patient positioning on the operating table is difficult. 
Intraoperative difficulties could arise in dislocation of the hip, the presence of 
osteophytes and in hips that are ankylosed the neck has to be osteotomised and 
the acetabulum reamed with the head in situ. Intraoperative bleeding is another 
concern. The other problems associated with surgery in ankylosed hips is the 
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choice of the implants, their positioning and consideration with respect to the 
increased joint reaction forces in patients with significant spine stiffness. 
Due importance must also be given to the deformities that are seen. The 
presence of external rotation deformity, exaggerated femoral anteversion and 
extension deformity need to be taken into consideration. Exaggerated 
anteversion of the hip may lead to intraoperative difficulties like impingement 
of the prosthetic neck or the greater trochanter posteriorly. This can be over 
come by using modular stems or extensively coated stems with a distal fixation. 
The bone is also osteoporotic and over reaming may compromise the acetabular 
or the femoral bone stock. 
Deliberate preservation of a spike of bone in the superolateral margin of the 
acetabulum  provided purchase for an uncemented cup as described by S Bhan 
et al. Tang and Chiu described the hyperextension deformity leading to a more 
vertically placed and anteverted cup predisposing the hip to an anterior 
dislocation44.  
Presence of adduction or abduction deformities tends to tilt the pelvis in the 
lateral position during surgery. The deformities may lead to a malpositioning of 
the acetabular component. Acetabular malpositioning may increase the risk of a 
post operative dislocation. Yong Lae Kim et al however showed that this 
projected high risk of post operative dislocation however does not occur 
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probably due to the repositioning of the greater trochanter and due to the limited 
range of motion post operatively. There is also no evidence that a malpositioned 
cup increased the polyethylene wear, osteolysis, or implant loosening. The 
hyperextension deformity seen in these patients is attributed to the spinal 
kyphosis leading to a hyperextension of the hips to improve the visual angle. 
Post operatively patients face difficulties such as unpredictable gain in range of 
motion and high incidence of ectopic bone formation and reankylosis45.  
The post operative range of motion is usually less than optimal. This poor post 
operative range of motion in AS can be attributed to the inactive hip muscles 
which are usually weak due to disuse. Understandably this range of motion is 
better in patients with a better pre operative range of motion than the patients 
with ankylosis. Other causes for a poor range of motion post operatively in 
patients with an ankylosis are poor muscle strength, myositis ossificans, long 
standing disease and the basic nature of the disease itself. 
Heterotopic ossification (HO): 
Rates of heterotopic ossification as high as 40%-76% have been reported in 
literature. The rate of developing heterotopic ossification at a second procedure 
if the first procedure produced heterotopic ossification is almost 4% to 61.7%. 
There is a risk of reankylosis with rates of 6%-10 % being shown in literature.  
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D J Kilgus et al showed that after an initial operation on the hip, patients who 
have Class-Ill or IV heterotopic bone (or, possibly, a large amount of Class-I 
heterotopic bone, with large fragments of heterotopic bone in the soft tissues) 
are at high risk for the development of a clinically important amount of 
heterotopic bone after a second operation on the same hip and in the 
contralateral hip after an operation on that hip46. Several patient related risk 
factors such as age, male sex, hypertrophic osteoarthritis, ankylosing 
spondylitis, diffuse idiopathic skeletal hyperostosis, and history of HO have 
been implicated47. However, soft tissue trauma is considered to be the main 
initiating factor for development of HO48. Kilgus D et al however in their study 
of 53 THA over a mean period of 6.3 yrs showed that having AS is in itself not 
a significant risk for developing HO and that other factors such as occurrence of 
severe HO in an earlier operated hip, infections in the hip and patients who has 
complete bony ankylosis preoperatively were at risk of developing significant 
HO46. When the hips are ankylosed preoperatively, the patient may also be at 
increased risk. Any form of prophylaxis be it NSAIDS or radiation have their 
own side effects and the choice of prophylaxis should be chosen keeping in 
mind the risks and benefits. As it is possible to identify patients who are more 
predisposed to formation of HA it would be better to limit prophylaxis to such 
patients.  
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In patients with bilateral involvement it is observed that operating both hips at 
the same time is more beneficial functionally than staging the surgery into two 
parts. This is explained by the fact that the deformity in the un-operated side 
undermines the functional benefit gained by the operated side.  
Deformities of the spine also need to be addressed if they contribute to the 
functional disability. Kyphotic deformities of the spine are seen in AS. Prior to 
correction of the spine deformity the hip flexion deformity has to be corrected 
and if a flexion deformity continues to persist then the spinal deformity needs to 
be corrected.  
Arthroplasty in ankylosing spondylitis: 
Cemented or Uncemented: The decision to use cemented or uncemented 
largely remains with the surgeon. There are numerous studies which show that 
both cemented as well as uncemented arthroplasty produce comparable results. 
However surgeons prefer uncemented arthroplasty in younger individuals as the 
bone stock is better and the bony ingrowth in uncemented arthroplasty being 
preferable to the cemented implant. In comparing cemented with uncemented in 
patients with AS, cemented acetabular cups showed a higher incidence of 
lucencies in the bone cement interface as described by Kilgus et al46. Joshi et al 
in a study of 181 hips with a follow up of 27 yrs showed excellent pain relief in 
about 97% of the patients and excellent hip function in about 65%49. Bhan S et 
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al retrospectively reviewed 54 patients and 92 hips treated with uncemented 
arthroplasty and showed that the results were good50. Brinker M et al in a study 
of 20 uncemented hips followed up over a period of 75 months showed a good 
outcome in his results. The results when compared with other series of 
cemented arthroplasty did not show a significant difference in outcomes51.  
In AS most of the patients requiring arthroplasty are of the younger age group 
and more of the recent studies show a preference to uncemented implants and 
articular surface replacement.  
Articular surface replacement (ASR): Articular surface replacement provides 
the advantage of a larger range of motion with a greater stability. This is useful 
as patients can be mobilized early reducing the occurrence of post operative 
stiffness or reankylosis which is common in patients with AS. The other 
advantages in using ASR is that AS being more common in younger patients 
who have good bone stock, this technique preserves the femoral bone stock, it 
increases stability, further improves the biomechanics and loading properties 
and easy conversion to a formal THA if needed. Early mobilization of the hip 
can be attempted as the hip is very stable and early mobilization prevents 
stiffness. Thus ASR is beneficial in the younger patient. There is however a 
dearth of literature on long term outcomes in ASR.  
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Disadvantages of ASR are in the incidence of metallosis in metal on metal 
bearing surfaces and is a significant problem especially in women of child 
bearing age group. Another disadvantage is the cost.  
Technical problems arise during surgery in patients with AS who have bony 
ankylosis or severe arthritis in which cases it becomes very difficult to dislocate 
the hip. A bony ankylosis is a contraindication for ASR. However an isolated 
study by Jia Li et al describes the procedure the followed for ASR in patients 
with AS even in the presence of bony ankylosis. The joint is isolated by 
removing the ankylosis and dislocated before the articular resurfacing could be 
attempted. It is technically demanding and requires precision in isolating the 
normal anatomical hip rotation centre in an ankylosed joint.  
Krishna Reddi B S R et al showed that there is a significant increase in the 
incidence of heterotopic ossification in ASR possibly due to a larger tissue 
dissection52. Cuckler et al compared heads of diameters 28mm and 32 mm and 
showed that the head with a larger diameter had a better range of motion, 
thereby showing that the range of motion improvement in ASR would be 
significant53.  
There is a dearth of literature on ASR in patients with AS and results of ASR 
done on patients with osteonecrosis have to be considered. 
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Jia Li et al has shown that ASR in young AS patients has the advantage of a 
good range of motion, early mobilization, low dislocation rate and an easier 
conversion to a total hip arthroplasty54. 
Hemiarthroplasty:  Bipolar hemiarthroplasty, though not described vastly in 
literature has been shown by Bhan S et al55.to be effective in patients with AS. 
He advocates the use of the bipolar implants in patients with either bony or 
fibrous ankylosis as the acetabulum created from a bed of cancellous bone from 
the ankylosis may not be suitable for acetabular fixation. Moreover he shows 
that there were no cases of HO in his series attributing it probably to the shorter 
operating time, less extensive surgery, less bleeding or haematoma formation, 
minimal soft-tissue dissection and the fact that the greater trochanter was not 
detached in any case.   
Furthermore as the greatest movement in a bipolar prosthesis occurs at the inner 
bearing, this significantly diminishes the reaction from tissue friction and 
possibly protects against the development of heterotopic ossification.   
In addition the self aligning cup in the bipolar prostheses is more suitable in 
patients where excessive ankylosis makes it difficult to orient the implant in the 
correct direction. 
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Spine involvement in ankylosing spondylitis: 
Spine involvement in AS is very relevant due to the associated effects of a 
deformed spine on the hip in terms of function, range of motion and joint 
reaction forces. In severe AS there is a fusion of the spine and a resulting 
kyphosis develops, probably attributed among other things to the habit of using 
pillows under the neck.  
As the kyphosis progresses and becomes severe there is a gradual drop in the 
horizon and the visual axis is sometimes perpendicular to the ground. In such 
cases it becomes very difficult for the patient to be functionally independent. 
The deformity is further compounded by a stiff or ankylosed hip. The patient 
also develops severe thoracic and abdominal pain. 
The patients are also predisposed to develop fractures of the vertebrae.  
Only recently has osteoporosis been identified as a major risk factor for the 
occurrence of fractures. The presence of osteoporosis of the femoral neck with a 
relatively larger amount of osteoporosis of the posterior spine as compared with 
the anterior spine shows that inflammation is the cause for the decreased bone 
mineral density23.  
The presence of a low bone density with a rigid spine with a poor tolerance to 
stresses is susceptible to fractures even with forces of low intensity. 
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Neurological complications also occurred with lower intensity forces rather 
than high energy trauma.  
Wedge osteotomies for the spine were described first by Smith Petersen, 
Larsson & Aufranc in 1945. Later La Chapelle (1946) and Herbert (1955) 
corrected deformities of the spine in two stages. Briggs, Keafs & Schlesinger 
(1947), Law (1949) and Adams (1952) preferred immediate correction on the 
operating table as well as fusion. Karel Styblo et al in a series of 22 patients 
conducted corrective osteotomies on the spine. They advocate a correction of 
about 40°-50° of compensatory lumbar lordosis at either L2-L3 or L4-L5 which 
are considered safe levels. 
Functional assessment in patients with AS:  
Ankylosing spondylitis affects patients in every aspect of their life. The patients 
are affected by the disease itself, its systemic manifestations and the deformities 
that result from the disease. They are sometimes so crippled by the disease that 
they are completely dependant on their family members for their activities of 
daily living.  
Assessment of a patients with AS cannot be restricted to one or two domains 
but must assess various aspects of the disease. This has led to the development 
of patient assessed health instruments which measure the health related quality 
of life in theses patients. These health instruments are in the form of 
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questionnaire involving specific questions which may be in the form of a set of 
choices or a visual analogue scale. Some of the more popular indices that assess 
the patient are the Bath indices and the Dougados functional index. A review of 
all theses patient assessed health instruments showed that the Bath Ankylosing 
Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing 
Spondylitis Functional Index (BASFI) and the Dougados Functional Index 
(DFI) had the greatest amount of evidence for reliability, validity and 
responsiveness across a range of settings56. The BASFI was shown to be a 
better scoring system in terms of distribution, reproducibility and reliability by 
Calin et al when compared with the Dougados functional index. 
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MATERIALS AND METHODS 
This is a retrospective study where all patients with ankylosing spondylitis who 
fit into the Modified New York criteria, with painful arthritis or ankylosis of the 
hip and who underwent primary hip arthroplasty between January 2005 and 
June 2009 were included in the study. Exclusion criteria for this study were: 
1. Patients with spondyloarthropathy or with any form of inflammatory 
arthritis who did not fit into the Modified New York criteria. 
2. Patients who underwent revision surgery. 
 A total of 45 patients were identified for the study based on the operation 
theatre register, inpatient and outpatient records. Correspondence was sent to 
their latest known addresses inviting them to participate in the study. Contact 
numbers were used when available. The mean duration of follow up in this 
study was 15.44 (3-52) months. This study was conducted in the department of 
Orthopaedics, Christian Medical College, Vellore between June 2008 and 
August 2009. 
The study was approved by the ethics committee of the hospital. 
Of the 45 patients reviewed, 24 patients responded. Of the 21 patients who 
could not be included in the study, 10 had come for follow up prior to the 
period in which the study was conducted and did not come for any further 
follow up. 11 of them never came for follow up after surgery. As the patient’s 
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response was required in the form of answering questionnaires and being 
present for a clinical assessment, these 21 patients could not be included in the 
study. However the 10 patients who had come for follow up prior to the period 
of the study were assessed based on the documentation from their out patient 
records and all ten of them were reported to be ambulant and were doing well in 
terms of their function. There was no documentation of any adverse outcomes 
in these patients as recorded in their out patient records at follow up. 
The 24 patients who came for follow up were interviewed on a personal basis. 
Informed consent was taken. Interviews were conducted for obtaining the 
relevant history and applying the questionnaires.  
Functional assessment of the patients was done using two scores: The Harris 
hip score and the Bath ankylosing spondylitis functional index. Clinical 
examination was done to assess the range of movement of the hip or hips. 
Radiographs taken at the time of follow up were used to assess the presence and 
grade of heterotopic ossification. The classification system described by 
Brooker et al was used to classify the HO. 
PATIENT DEMOGRAPHY 
Of the 24 patients who were included in the study, 22(91.6%) were men and 
2(8.3%) were women. The mean age of the patients was 37.16 yr (18-62).  
12(50%) patients had bilateral hip arthroplasty and 12(50%) unilateral.  
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Of the 36 hips operated 18(50%) were on the left side and 18(50%) on the right 
side.  
Of the 24 patients, 13(54.2%) patients underwent cemented arthroplasty, 
5(20.8%) underwent uncemented arthroplasty and 6(25%) underwent articular 
surface replacement. Of the 36 hips operated, 20(55.6%) underwent cemented 
arthroplasty, 5(13.8%) underwent uncemented arthroplasty and 11(30.6%) 
underwent articular surface replacement.  
The mean age of patients undergoing cemented arthroplasty was 41.1 yrs, in 
patients undergoing uncemented arthroplasty it was 32.2 yrs and in patients 
undergoing articular surface replacement it was 32.27 yrs. 13(54.16%) patients 
and 17(47.22%) hips had bony ankylosis. 16 0f the 24 patients received 
prophylaxis for heterotopic ossification in the form of oral Indomethacin. 
Table 2: Patient demography 
 Patients Hips 
Total patients 24 36 
Male n (%) 22 (91.6%) 34 (94.4%) 
Female n (%) 2 (8.3%) 2 (5.5%) 
Left side n (%) 12 (50%) 18 (50%) 
Right side n (%) 12 (50%) 18 (50%) 
Bilateral n (%) 12 (50%) - 
Bony ankylosis n (%) 13 (54.16%) 17 (47.22%) 
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OPERATIVE PROCEDURE 
All patients who were planned for surgery were seen and evaluated initially in 
the out patient department and were admitted 1 to 2 days prior to the day of 
surgery. They were thoroughly examined and clerked by the junior residents. 
Surgeries were done by two surgeons with vast experience in arthroplasty. The 
surgeries were performed either in the supine or lateral positions. 
The approaches used were: 
1. Posterior Moore approach in lateral position. 
2. Modified Hardinge Lateral approach in supine/lateral position. 
3. Lateral approach with trochanteric osteotomy in lateral position. 
All patients were administered preoperative prophylactic IV antibiotics. None 
of the patients received any form of thromboembolic prophylaxis.  
16 of the 24 patients received prophylaxis for heterotopic ossification in the 
form of oral Indomethacin. Patients undergoing cementing underwent second 
generation cementing technique. Wounds were close with suction drains and an 
abduction pillow was placed between the legs in the immediate post operative 
period itself.  
The patients were shifted into a special arthroplasty room for the first 48 hrs 
following surgery. Thromboembolic prophylaxis was started on the night of 
surgery itself in the form of mechanical prophylaxis such as ankle-pump 
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exercises, calf muscle squeezing and sequential compression device. All 
patients followed a physical therapy regimen starting on the first postoperative 
day when they started isometric knee extension and hip abduction exercises. 
Drains were removed two days after surgery and radiographs were taken. 
Intravenous antibiotics were continued at least till drain removal and then 
changed to oral antibiotics depending on the surgeon’s preference.  
Full weight-bearing ambulation with bilateral axillary crutches was started after 
X-rays 48 hours following surgery. Patients with bilateral total hip replacements 
were initially ambulated full weight-bearing with a walker and gradually 
progressed to crutch walking. During the post operative period they were taught 
a home program to be followed at home following discharge. Suture removal 
was done on the 10th post operative day and they were restarted on any 
DMARDs they were on.  
They were advised follow up at 3 months. 
ASSESSMENT OF FUNCTIONAL OUTCOME 
Patients were assessed functionally with two scores. 
1. Harris Hip Score 
2. Bath Ankylosing Spondylitis Functional Index (BASFI) 
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The Harris hip score assessed the patient in four domains 
    1. Pain – 44 points 
    2. Function – 47 points 
         Gait – 33 points 
         Activities of daily living – 14 points. 
4. Absence of deformity – 4 points 
5. Range of motion – 5 points. 
A total score of 90-100 was considered as excellent, 80-89 good, 70-79 fair and 
below 70 poor. The BASFI is a set of 10 questions each answered in the form of 
a visual analogue scale marked between 0 to 10, 0 being easy and 10 being 
impossible. The first 8 questions considered activities related to functional 
anatomy. The last 2 questions relate to the patients ability to cope with 
everyday life. The score was totaled and divided by ten. A score closest to zero 
was the best possible score. Patients were asked to answer the questions and fill 
out the forms at follow up. The pre operative scores were taken at the time of 
follow up as the study was retrospective in nature. The pre operative range of 
motion was assessed from the old inpatient charts or the discharge summaries. 
The patients were clinically examined to assess the range of motion and any 
deformities if present.  
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Other parameters that were compared were pre and post operative improvement 
in range of motion, pain score using the Harris hip score. 
Radiological assessment was made at the time of follow up to assess any 
ectopic bone formation. The assessment of ectopic bone formation was done 
using the classification described by Brooker et al57. 
 
Table 3: Brookers classification of ectopic calcification 
Class 1 Islands of bone within the soft tissues about the hip 
Class 2 Bone spurs from the pelvis or proximal end of the femur, leaving at least 
one centimeter between opposing bone surface 
Class 3 Bone spurs from the pelvis or proximal end of the femur, reducing the 
space between opposing bone surfaces to less than one centimeter 
Class 4 Apparent bone ankylosis of the hip 
 
Additional surgeries: One patient underwent adductor tenotomy, while three 
patients underwent adductor tenotomy, Souttars release and Yount`s release.  
One patient at follow up underwent bilateral total knee arthroplasty for a 
bilateral 30° fixed flexion deformity. 
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RESULTS 
The scores were analyzed using SPSS 12.0® software for Windows®.  
All patients experienced a substantial clinical improvement in terms of pain, 
function and range of motion. At a mean follow up of 15.44 months (3 to 52 
months), the mean pre operative Harris hip score improved from 30.89/100 (SD 
of 19.58; range 2-73) to 82.63/100 (SD of 7.816; range 57-96) at the time of 
follow up. This was statistically significant (p<0.05). 
The mean preoperative BASFI score improved from 7.51/10 (SD of 1.445; 
range of 4.2-9.4) to 3.93/10 (SD of 1.372; range of 1.4-6.7) at the time of follow 
up. This was statistically significant (p<0.05). 
The mean pre operative Harris hip score improved from 28.9/100 (SD of 
20.013; range of 2-73) to 83/100 (SD of 6.989; range of 71-96) in the cemented 
group, 33/100 (SD of  23.484; range of 5-58) to 76.4/100 (SD of 12.462; range 
of 57-91) in the uncemented group and 33.27/100 (SD of 18.553; range of 8-57) 
to 84.82/100 (SD of 5.828; range of 75-92) in the ASR group. This was 
statistically significant (p<0.05). 
The average BASFI score improved from 7.48/10 (SD of 1.313; range of 4.6-
9.2) to 4.06/10 (SD of 1.451; range of 2.5-6.4) in the cemented group, 6.96/10 
(SD of 1.957; range of 4.2-8.4) to 4.56/10 (SD of 1.27; range of 3-4.4) in the 
uncemented group and 7.83/10 (SD of 1.494; range of 6.6-9.4) to 3.42/10 (SD 
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of 1.191; range of 1.4-6.1) in the ASR group. This was statistically significant 
(p<0.05).  
The pain score improved from 13.72 out of 44 pre operatively to 42.05 out of 
44 postoperatively. This was statistically significant (p<0.05).The average 
preoperative pain score improved from 14.2 to 42.4 in the cemented group, 12 
to 38.8 in the uncemented group and from 13.64 to 42.91 in the ASR group. 
This was statistically significant.  
At follow up 21(58.33%) hips were completely pain free, 14(38.9%) hips had 
slight to occasional pain and 1(2.77%) hip had mild pain. 7(19.44%) hips 
showed an excellent outcome, 20(55.56%) hips showed a good outcome and 
9(25%) hips showed a fair outcome using the Harris hip score. 
The average preoperative range of motion improved from 32.5° (0°-135°) to 
184.3° (110°-280°) at follow up. This was statistically significant (p<0.05). The 
average gain in range of motion was 151.8° (15°-210°). The average 
preoperative range of motion improved from 15° to 177° in the cemented 
group, 35° to 176° in the uncemented group and from 63° to 200 ° in the ASR 
group. This was statistically significant (p<0.05). 
Ectopic bone formation was observed in 7 hips with Grade 1 in 6 hips and 
Grade 2 in one hip. 
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The Harris hip score, BASFI, range of motion and pain scores were compared 
within the cemented, uncemented and ASR groups and it was found that there 
was no significant difference between the groups.  
Two groups of patients, those who underwent bilateral hip surgery at one sitting 
and those that underwent bilateral hip surgery in two stages were also compared 
and the Harris hip score improved from 28.14 to 84.85 in the first group and 
from 38.4 to 84.5 in the second group. The BASFI score improved from 7.8 to 
3.5 in the first group and from 7.24 to 4.33 in the second group. The range of 
motion improved from 38.21° to 174.28° in the first group and from 33.5° to 
195° in the second group. The pain score improved from 13.14 to 42.28 in the 
first group and from 17 to 42.8 in the second group. There was no significance 
in the improvement in the scores between the two groups. 
Complications: One patient developed chicken pox during the post operative 
period and received oral Acyclovir. He had an uneventful recovery. Three 
patients were already on anti tubercular treatment for pulmonary tuberculosis at 
the time of surgery. There were no other complications. 
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Table 12: Comparing within the cemented, uncemented and ASR groups: 
ANOVA 
 
 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
Harris hip score post op Between Groups 249.469 2 124.735 2.179 .129 
Within Groups 1888.836 33 57.237  
Total 2138.306 35   
BASFI post op Between Groups 5.179 2 2.589 1.408 .259 
Within Groups 60.678 33 1.839  
Total 65.856 35   
Range of motion post op in 
degrees 
Between Groups 3913.889 2 1956.944 2.087 .140 
Within Groups 30943.750 33 937.689  
Total 34857.639 35   
pain post op Between Groups 63.380 2 31.690 4.743 .015 
Within Groups 220.509 33 6.682  
Total 283.889 35   
 
Table 13: Comparing pain scores within the groups: 
Multiple Comparisons 
Dependent Variable: pain post 
Bonferroni 
 Mean Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence Interval 
(I) 
SURGERY 
(J) SURGERY Lower 
Bound 
Upper 
Bound 
Cemented Uncemented 3.60(*) 1.292 .026 .34 6.86 
ASR -.51 .970 1.000 -2.96 1.94 
Uncemented Cemented -3.60(*) 1.292 .026 -6.86 -.34 
ASR -4.11(*) 1.394 .018 -7.63 -.59 
ASR Cemented .51 .970 1.000 -1.94 2.96 
Uncemented 4.11(*) 1.394 .018 .59 7.63 
* The mean difference is significant at the .05 level. 
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Table 15:                                                                           Group Statistics 
 GROUP N Mean Std. Deviation Std. Error Mean 
Harris hip score One stage 14 84.86 7.199 1.924 
Two stage 10 84.50 5.191 1.641 
BASFI One stage 14 3.500 1.0138 .2709 
Two stage 10 4.330 1.5671 .4955 
Range of motion One stage 14 174.29 25.333 6.771 
Two stage 10 195.00 41.966 13.271 
Pain score One stage 14 42.29 2.054 .549 
Two stage 10 42.80 1.932 .611 
Comparing one and two stage operated bilateral hip patients 
Table 16:                                                                                     Independent Samples Test 
 Levene's Test 
for Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Harris 
hip 
score 
Equal 
variances 
assumed 
1.898 .182 .134 22 .895 .36 2.672 -5.184 5.898 
Equal 
variances 
not assumed 
  .141 21.987 .889 .36 2.529 -4.888 5.602 
BASFI Equal 
variances 
assumed 
2.955 .100 -1.579 22 .129 -.830 .5257 -1.9202 .2602 
Equal 
variances 
not assumed 
  -1.470 14.300 .163 -.830 .5648 -2.0389 .3789 
Range 
of 
motion 
Equal 
variances 
assumed 
1.900 .182 -1.509 22 .146 -20.71 13.730 -49.189 7.760 
Equal 
variances 
not assumed 
 -1.390 13.655 .187 -20.71 14.898 -52.743 11.315 
Pain 
scores 
Equal 
variances 
assumed 
1.540 .228 -.619 22 .542 -.51 .830 -2.236 1.207 
Equal 
variances 
not assumed 
 -.626 20.257 .538 -.51 .821 -2.226 1.198 
Comparing one and two stage operated bilateral hip patients 
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Discussion 
Total hip arthroplasty has been shown to be one of the most rewarding surgeries 
in orthopaedics in terms of patient function, pain relief, stability and range of 
motion. There has been a lot of concern in THA in patient with AS as the 
average patient with AS is very young. Several reports are present in literature 
showing that there is improvement in hip function and patient satisfaction after 
THA. Current literature has progressed from earlier studies which focused on 
smaller patient numbers and the use of cemented arthroplasty to studies that 
have larger patient numbers and larger duration of follow up42,44,46,49,50. The use 
of cementless and even articular surface replacement has been studied50,51,55. 
Specific studies on patients with ankylosis of the hips and surgery on bilateral 
hips also have been documented and have shown significant improvement in 
function, pain relief and range of motion50,58. The specific problems faced when 
considering arthroplasty in patients with AS is the age of the patient and the 
presence of ankylosis of the joint for which the patient may actually present 
without any pain. There is a risk of HO, stiffness, reankylosis and other 
complications. 
A review of literature showed that a lot of work has been done in arthroplasty in 
patients with ankylosing spondylitis 
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Table 17: Summary of studies in literature on arthroplasty in AS: 
Year Authors No of 
patients 
No of 
hips 
follow up 
yrs 
1970 Welch and Charnley 20 31 2.6  
1972 Arden et al 10 14 >1? 
1976 Bisla et al 23 34 3.5 
1977 Williams et al 53 86 3 
1977 Baldursson et al 10 18 3.8 
1982 Shanahan et al 12 16 7.4 
1987 Toni et al 22 28 2-14 
1988 Finsterbush et al 23 35 8 
1989 Calin and Elswood 87 138 7.5 
1990 Kilgus et al 31 53 6.3 
1991 Walker and Sledge 19 29 4.6 
1995 Shih et al 46 74 8.3 
1996 Brinker et al 12 20 6.2 
1996 Bhan and Malhotra 12 19 3.8 
1997 Sochart and Porter 24 43 22.7 
2000 Tang and Chiu 58 95 11.2 
2001 Joshi et al 103 181 10.3 
2007          Yong Lae Kim et al          12           24          >3 
2008          Surya Bhan et al          54           92          8.5 
2009          Jia Li et al          24           39          2 
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Clinical results: 
The results of this study are in the acceptable range for successful outcome after 
arthroplasty. The Harris hip score improved from 30.8 to 82.6 with an 
improvement of 51.8 points and showed a significant clinical result (p<0.05). 
This is comparable to Brinker M et al who showed a 40.7 point improvement in 
the Harris hip score(48.4 to 89.1)51. 27(75%) hips showed a good to excellent 
outcome which is comparable to earlier studies such as Williams’s et al (73% 
excellent outcome) with 86 cemented arthroplasties59. Calin and Elswood 
reported 86% good or very good results in 138 primary and 12 revision hips2. 
Bisla et al showed a 91% good clinical report of 34 cemented hips60. Joshi et al 
reported that their series of follow up scores showed on a 65% excellent while 
96% showed excellent pain relief. They attributed it to the advanced age at 
follow up49.  
Our study also showed an improvement in the BASFI score with an 
improvement from 7.51 to 3.93 with 0 being the best possible score. This was a 
significant improvement in the function of the patient as a whole (p<0.05). The 
BASFI score has never been used in the earlier mentioned studies (table 17). It 
is a score predominantly used in assessing progress of treatment in patients on 
medical and physical therapy. Since AS affects the person as a whole and a 
surgery such as a THA can provide a significant functional improvement the 
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BASFI score was used in our study and clearly shows an improvement in the 
scores. An improvement in the BASFI score also suggests that THA may not 
just benefit the patients function as related to the hip alone but as a person on 
the whole. BASFI has been described as having the greatest amount of evidence 
for reliability, validity and responsiveness across a range of setting for assessing 
a patient’s health56. The above results clearly show that THA provides the 
patient with a great amount of functional improvement. 
Pain: In our study 21(58.33%) hips were completely pain free, 14(38.9%) hips 
had slight to occasional pain and 1(2.77%) hip had mild pain post op. This was 
statistically significant (p<0.05). Brinker M et al showed in their study of 20 
hips that 90% i.e. 18 out of 20 hips had slight or no pain at recent follow up51. 
They also added that there was no significant difference in the pain scores 
between cemented and uncemented arthroplasty. Bisla et al reported mild or no 
pain in 94% of 34 cemented arthroplasties60. Similarly Halley and Charnley61 
and Wech and Charnley62 showed no pain in all their 17 and 33 cases 
respectively. Walker and Sledge showed no pain in 97% of 29 hips following 
cemented THA63. Calin and Elswood showed a complete relief in pain in 89% 
or 123 of 138 hips2. However Bhan S et al showed appearance of pain in 37 
(38%) of 92 hips following uncemented arthroplasty. This was attributed to the 
fact that the patients in his study had bony ankylosis and had no preoperative 
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pain. He also suggests that the patient be counseled for the post operative 
pain50. We also noticed that the patients who had undergone uncemented 
arthroplasty had a less significant improvement in pain scores post op. This 
could be attributed to the fact that this group had a much worse pain score to 
start with preoperatively and the result may not reflect on the implant used. 
Hip range of motion: In our study the mean preoperative range of motion 
improved from 32.5° to 184.3° at follow up. The mean improvement in the 
range of motion being 151.8°. This was a significant improvement (P<0.05). 
Bhan S et al in their study of 54 patients and 92 ankylosed hips showed a post 
operative range of motion of 156.2°50. Sochart et al showed in his study of 43 
cemented hips that the mean post operative range of motion improved to a score 
of 5 (160°-216°)42. Kilgus et al46 in their study showed a post operative range of 
motion of 176° and Bisla et al60 in their study showed a post operative range of 
motion of 147.6°.  
These ranges of motions were lesser that the ranges of motion attained in hip 
arthroplasty for other indications such as hip arthroses, as there are other factors 
that cause a lower post operative range of motion in patients with ankylosing 
spondylitis. Kilgus in his study identified causes which may produce a poor 
postoperative range of motion such as formation of severe heterotopic 
ossification, post operative infection, previous operations on the hip and a poor 
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preoperative range of motion. Walker and Sledge demonstrated a post operative 
range of motion of 168°63.  
Bhan S et al in their study of 19 hips which underwent bipolar hemiarthroplasty 
showed a post operative range of motion of 182.5° which was attributed to the 
advantage of using a bipolar hemiarthroplasty55. 
Heterotopic ossification: In our study we noticed seven hips (19.44%) with 
heterotopic ossification with one hip showing Brooker class 2 HO and six hips 
showing Brooker class 1 HO.  
This was lower than other studies such as Bisla who showed a high rate of HO 
of upto 61.7%60. In our study 16 out of the 24 patients received Indomethacin as 
prophylaxis. Kilgus et al showed class 1 HO in 25% (13 hips), class 2 HO in 
9% (5 hips) and class 3 HO in 9% (5 hips). He further predicted that 
development of class 1 HO in one hip does not predict development of HO in 
the other hip. He also concluded that all patients in who class 3 HO developed 
in one hip class 2 or worse developed in the contralateral hip. His study showed 
an increased incidence of HO in hips that were pre operatively ankylosed46. 
Joshi et al showed an incidence of 11.6% (21 hips)49. Studies by Arden et al 
showed that 14.35% of the patients developed HO64. Welch and Charnley 
showed an incidence of 1.9% HO in a mixed group of patients with both 
rheumatoid arthritis and ankylosing spondylitis62.   
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Brooker reported a 21% incidence of HO in non ankylosing spondylitis patients 
although significant amounts of HO were seen only in 9% of the cases57. 
Studies in non ankylosing patients have shown the rate of formation of 
heterotopic ossification ranged from 8 to 90%. Harris showed an incidence of 
14% where only 3% of the patients were significantly affected in terms of range 
of motion65.  
Bisla concluded from these studies showing formation of HO in mixed groups 
of patients who had undergone arthroplasty that even though varying degrees of 
HO occurs in patients with AS it is significant only in a small percentage where 
it is disabling60. Bhan S et al in their study on bipolar hemiarthroplasty showed 
that there was no formation of HO in their series of 19 hips. He attributed the 
lack of HO to a shorter operating time, less extensive surgery, less bleeding or 
hematoma formation, minimal soft tissue dissection and absence of a 
trochanteric osteotomy55.  
Tang and Chiu reported a 21% incidence of class 3 to 4 HO and attributed it 
probably to the fact that no prophylaxis was given for the HO. Bhan s et al in 
their study of 92 hips undergoing uncemented arthroplasty reported an 
incidence of only 13% (12 hips) which they attributed to the use of 
Indomethacin as a prophylaxis for a period of two weeks and which they further 
recommend50.  
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However Brinker et al in their study stated that after a complete review of 
literature they found that the differences in the rates of HO in various studies 
could result from the use of dissimilar grading systems, differences in 
techniques, failure in distinguishing between patients who have had one or 
more surgeries and differences in patient populations. He further states that 
patients with AS are not specially predisposed to form HO51. Giordani et al in 
their study of 25 THAs showed HO in only one hip and concluded that the 
incidence of HO in patients with AS is similar with the general population and 
prophylaxis need not be taken66.  
Even though prophylactic radiation has been shown to be effective in 
preventing HO, it has shown to decrease the strength of fixation of porous 
coated implants and produce non union if a trochanteric osteotomy was done67. 
There is also a theoretical risk of developing a malignancy and anaemia 
following radiation. 
Comparing implants: In our study the post operative scores showed an 
acceptable and a significant outcome for all three implants used i.e. cemented, 
uncemented and ASR. The BASFI score also showed a significant improvement 
post operatively for all the implant groups. On comparing the improvement in 
range of motion between the implants used it was seen that all three groups 
showed a significant improvement. The improvement in pain was also 
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significant for each of the groups. On comparing between groups there was no 
significant difference between groups.  
Studies in which cemented and uncemented implants were use did not show an 
appreciable difference in the outcomes44,46,58. Kilgus et al in their study of 53 
hips with cemented, uncemented and surface replacement did not show a 
comparable difference between the three groups, and they however noticed a 
higher incidence of narrow radiolucencies at the acetabular interface and 
observe that there may be a greater role in the use of uncemented implants46. 
Table 18: Comparing between implant groups 
 Harris 
hip 
score 
pre op 
Harris 
hip 
score  
post 
op 
BASFI 
pre op 
BASFI  
post op 
Pre op 
range 
of 
motion 
in 
degrees 
Post op 
range 
of 
motion 
in 
degrees 
Pains 
score 
pre 
op 
Pain 
score 
post 
op 
Cemented 28.9 83 7.48 4.06 15 177 14.2 42.4 
Uncemented 33 76.4 6.96 4.56 35 176 12 38.8 
ASR 33.27 84.82 7.83 3.42 63 200 13.64 42.91 
 
Comparing single stage and two stage surgeries for patients with bilateral 
hip involvement: We compared patients with bilateral hip involvement who 
underwent bilateral surgery in one stage and those that underwent surgery in 
two stages but found no statistically significant difference between the two 
groups. 
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CONCLUSION 
Total hip arthroplasty whether it is cemented, uncemented or articular surface 
replacement is very beneficial to the patient with ankylosing spondylitis who is 
affected with hip arthritis or ankylosis. A single surgery replacing the hip joint 
provides a dramatic relief in the patient’s pain, improves hip range of motion, 
improves function, provides independence in activities of daily living and 
allows return to normal function.  
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LIMITATIONS OF THE STUDY 
1. This is a retrospective study and offers only level three evidence. 
2. The functional outcome studied in these patients was done on a small 
number of patients who came for follow up during the period of the study 
and may not be representative of the entire group of patient’s. 
3. This study did not assess the long term survivorship of the implants, rates 
of revision and other parameters such as subsidence, loosening, wear rate 
etc. 
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Annexure 
Preoperative photo of a patient with ankylosing spondylitis: 
Fig 1: Sitting in a chair: 
 
Fig 2: Lying on a bed: 
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Photographs at follow up: 
Fig 3: Posterior approach both sides 
 
Fig 4: Flexion both hips 
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Fig 5: Lying down on a bed and squatting: 
 
 
Fig 6: Doing a straight leg raise: 
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X RAY IMAGES 
Fig 7: Pre operative X ray with an excision arthroplasty on the opposite side.
 
Fig 8: Pre operative X ray with bony ankylosis both hips.
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Fig 9: Pre operative X ray 
 
Fig 10: Post operative Xray following Cemented arthroplasty
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Fig 11: Pre operative X ray 
 
Fig 12: Post operative X ray following left uncemented arthroplasty. 
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Fig 13: Pre operative X ray 
 
Fig 14: Post operative X ray following bilateral ASR 
 
84 
 
Fig 15: Pre operative X ray 
 
Fig 16: Post op X ray following uncemented metal on metal arthroplasty 
with stainless steel wire following Split of the Greater trochanter 
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Fig 17: Post op X ray showing Brooker`s class 1 heterotopic ossification 
 
Fig 18: Post op X ray showing Brooker`s class 2 heterotopic ossification
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Proforma 
No: 
      Date:                                  
Hospital No: 
Name: 
Age: 
Sex: 
Permanent address: 
 
 
Phone no: 
Email ID: 
Duration of complaints: 
Other comorbidities: 
 
Occupation: 
Dates of admission and surgeries done: 
 
Duration of follow up: 
Charnley`s class:        A      B       C   
Operated side:            L       R       B/L   
Procedure done: 
Primary cemented THR                     Primary uncemented THR                                       
Primary resurfacing arthroplasty       Primary THR not classified   
Austin Moore prosthesis                    Thompson    
Cemented bipolar                               Uncemented bipolar    
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Consent form 
 Dr.Prabhu L Joseph 
 PG registrar 
 Dept of Orthopaedics, 
 CMC Vellore 632004, 
 India. 
 E mail ID- prabhujoseph24@rediffmail.com. 
  
Subject’s Name: _______________________ 
Address: 
 
Date of Birth / Age:  ______ 
Phone:  
The purposes of this project are: 
To study the functional outcome, in patients with ankylosing spondylitis, following hip 
arthroplasty. 
You will undergo relevant clinical examination, and will be required to answer a 
questionnaire. 
However benefit from this study to the patient for cure/improvement is uncertain. 
You are encouraged to ask any questions at any time about the nature of the study and 
the methods that I am using. 
1)  Your real name will not be used at any point of information collection, or in the 
written case report; 
2) Your participation in this research is voluntary; you have the right to withdraw at any 
point of the study, for any reason, and without any prejudice. 
I agree to the terms 
 
Respondent signature ___________________________ Date _____________ 
 
 
Researcher ___________________________ Date _____________ 
